Project Grant R01MH138347
Award Date
12/1/24
Completion Date
10/31/29
Dollars Obligated
$797K
Federal Agency
National Institute of Mental Health
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06519, USA
Similar Awards
This Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the mechanisms by which SARS-CoV-2 infection causes neurological damage and post-acute sequelae, commonly referred to as "long COVID". The $634,622 award to the Icahn School of Medicine at Mount Sinai will fund a 5-year project to acquire...
The National Institutes of Health National Institute of Mental Health awarded Yale University $7,389,444 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2022 for a project concluding on August 31, 2025. The award will support Yale University in conducting a multivariate investigation to identify latent factors linking internalizing disorders such as anxiety, major depressive disorder, and posttraumatic stress disorder with COVID-19 outcomes including infection,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will provide $1,979,679.00 over 5 years starting July 1, 2024 to the Icahn School of Medicine at Mount Sinai. The project aims to conduct non-invasive brain imaging to compare cerebral oxygen and glucose metabolism between patients with Post-Acute Sequelae of SARS-CoV-2...
This federal Project Grant award from the National Institutes of Health National Institute of Mental Health provides $6,499,884 to Yale University under the Mental Health Research Grants program (CFDA 93.242) to study the longitudinal nervous system consequences of SARS-CoV-2 in people with HIV-1 treated in early infection. The award will fund research from September 2022 to September 2025 to analyze pre- and post-COVID-19 data from a cohort of early antiretroviral therapy-treated people with...
The National Institute of Mental Health (NIMH) awarded a $1,932,991 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Yale University to conduct research on the neural computations underlying learning, decision-making, and memory. The 5-year grant, which runs from August 1, 2024 to March 31, 2029, will fund a behavioral study with 1,000 participants and a functional MRI study with 100 participants. The research aims to characterize core computations of value, uncertainty, and...
The National Institute on Aging (NIA) awarded a 3-year, $2,561,480 Project Grant (CFDA 93.866) to Brigham & Women's Hospital to study the post-acute sequelae of SARS-CoV-2 infection (PASC) and subsequent disease progression in individuals with mild cognitive impairment (MCI) or Alzheimer's disease (AD) and related dementias (ADRD). The project aims to: 1) understand the epidemiology of PASC in cognitively impaired individuals; 2) examine the impacts of COVID-19 and PASC on disease...
The National Institute of Mental Health (NIMH) awarded a $384,772 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Tennessee Health Science Center in Memphis, Tennessee. The award, titled "The Neuroimmune Mechanism of SARS-CoV-2 on Synaptic Transmission and Plasticity", aims to elucidate the cellular and molecular mechanisms by which SARS-CoV-2 infection alters neuronal activity in mice. The research will determine if SARS-CoV-2 infection induces...
The National Institute of Mental Health (NIMH) awarded a $194,157 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Icahn School of Medicine at Mount Sinai to develop and pilot a novel intervention to treat post-COVID-19 cognitive impairment (CI) and depression. The purpose of this 5-year study is to integrate evidence-based cognitive rehabilitation and cognitive behavioral therapy approaches, and adapt the intervention for ethnically diverse patients with post-acute sequelae of...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $183,096 to the University of Maryland, Baltimore to study the structural, functional, and neurobehavioral consequences of adolescent COVID-19 infection. The key objectives are to: 1) Identify morphometric and microstructural brain abnormalities associated with SARS-CoV-2 infection by analyzing longitudinal MRI data; 2) Determine if...
The National Institute of Mental Health (NIMH) awarded a $833,123 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Cedars-Sinai Medical Center to investigate the impact of SARS-CoV-2 infection and social determinants of health on inflammation-associated depression risk. The project aims to provide a detailed understanding of how upstream eicosanoid pathways are affected by SARS-CoV-2 and social determinants, and how these changes are associated with the...